Cancer patients receiving chemotherapy- or immunotherapy-based treatments must undergo regular CT and PET scans—and in some cases, new biopsies—to evaluate the efficacy of the treatment. Flow cytometry, a method for identifying circulating tumor cells (CTCs) via a simple blood test, is much less invasive than scans and biopsies, and could be a game-changer in cancer treatment.